Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03284359 · ClinicalTrials.gov registry record · NA

Use of Nudges To Enhance Enrollment in Critical Care Research

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
182
Enrollment target

NCT03284359: Completed NA study, sponsored by University of Pennsylvania.

NCT03284359 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 182 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03284359, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
182 participants
Enrollment target

Study Summary

Difficulties enrolling patients in randomized clinical trials (RCTs) have long been recognized as a major barrier to successful evaluation of medical interventions. This is particularly problematic among intensive care unit (ICU) trials, of which more than one-third do not reach target enrollment. Under-enrollment and selective enrollment reduce RCTs' abilities to answer the research questions, thereby degrading the trials' scientific value and ethics. Current evidence suggests that financial incentives can ethically increase study enrollment, but this approach can pose large up-front costs to researchers. However, several nonmonetary behavioral interventions, or nudges, may offer novel and easily scalable approaches to increase enrollment in RCTs. The investigation team propose a 2-arm RCT in 10 ICUs at Penn to test the relative effectiveness of nudges on enrollment rates. Investigators hypothesize that a bundle of nudges during recruitment will increase enrollment rates compared to usual recruitment procedures will increase enrollment. Investigators will enroll 182 critically ill patients' surrogate decision makers(participants) to engage in recruitment procedures for a simulated RCT comparing two mechanical ventilation weaning protocols among mechanically ventilated patients. Investigators will also measure participants' assessment of risk of the simulated trial after the informed consent process. This work will provide the first empirical evidence regarding the efficacy of inexpensive, scalable nudges to potentially augment enrollment and reduce costs of future clinical trials.

Primary Outcome

The primary outcome is consent rate for a simulated RCT. This is an easily measurable binary outcome that has the potential for significant impact on future trial recruitment.

Interventions

  • BEHAVIORAL Pre-Consent Nudge Bundle

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2018-02-19
Est. Completion 2019-08-08
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT03284359 record still lists

NCT03284359 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which Pre-Consent Nudge Bundle is the first listed.

NCT03284359 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03284359 about?

NCT03284359 is a clinical study titled "Use of Nudges To Enhance Enrollment in Critical Care Research". Difficulties enrolling patients in randomized clinical trials (RCTs) have long been recognized as a major barrier to successful evaluation of medical interventions. This is particularly problematic among intensive care unit (ICU) trials, of which more than one-third do not reach target enrollment. U...

What is the current status of trial NCT03284359?

This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2018-02-19. Estimated completion is 2019-08-08.

What interventions are being tested in trial NCT03284359?

The interventions under investigation include: Pre-Consent Nudge Bundle (BEHAVIORAL).

Who is sponsoring clinical trial NCT03284359?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03284359's enrollment target sits among peer trials

182 584th of 2000 higher than 1,415 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03897998 · 182 participants · Phase 2

    Neural Correlates of Hypoalgesia Driven by Observation

  • NCT04300556 · 182 participants · Phase 1

    A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

  • NCT04323735 · 182 participants · Phase 2

    Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters

  • NCT05606731 · 182 participants · NA

    Family Intervention to Prevent Childhood Obesity

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03284359, the US trial registry maintained by the National Library of Medicine. NCT03284359 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.